Does Medicare cover viscosupplementation treatment of the knee?
CIGNA Government Services does not have a local coverage decision for this treatment, but the following article addressing this issue has been previously published in our Medicare bulletin and details the guidelines still applied presently: http://www.cignamedicare.com/partb/bltin/all/99bltin/99_4/forall/Intraarticular%20knee%20injections.html In summary, sodium hyaluronates and hyaluronic acid derivatives approved by the FDA for the treatment of osteoarthritis of the knee joints are covered for patients who have failed to respond or had inadequate response to other treatments. Presently, there are five available drugs (Euflexxa, Hyalgan, Supartz, Orthovisc and Synvisc) that may be billed under the appropriate/corresponding HCPCS code of which there are two available: J7317, SODIUM HYALURONATE, PER 20 TO 25 MG DOSE FOR INTRA-ARTICULAR INJECTION (use for the Euflexxa, Hyalgan, Supartz and Orthosvisc) J7320, HYLAN G-F 20, 16 MG, FOR INTRA-ARTICULAR INJECTION (use for Synvisc) Note that e
Related Questions
- What conditions are covered for acupuncture? (Many plans only cover the treatment of pain) Do Medicaid and Medicare cover acupuncture?
- Update on sodium hyaluronates (previously published 060106): Does Medicare cover viscosupplementation treatment of the knee?
- Does Medicare cover viscosupplementation treatment of the knee?
